Living Launch Success 2.0 in a Brave New World: Lessons for Modern Launches from the GLP-1 Wave

Session details:

GLP-1 therapies haven’t just disrupted the obesity market — they’ve redefined what success looks like in health management. With unprecedented demand, cultural resonance, and cross-industry attention, these launches have challenged conventional thinking around stakeholder engagement, commercialization, and launch strategy.

But here’s the critical insight: the impact of GLP-1s extends far beyond obesity or cardiometabolic disease. Whether or not your pipeline includes a GLP-1, the ripple effects are reshaping expectations for every future launch.

This session explores the true drivers behind the GLP-1 phenomenon — what made these launches so successful, and what every brand team must take away to remain competitive in this new era. While GLP-1 launches don’t offer a one-size-fits-all blueprint, they do provide powerful lessons that can inform and elevate launch planning across the industry.